Lv13
70 积分 2025-07-28 加入
Potential Reversal of Alzheimer’s Disease pathology by Antibody TB006 Targeting Galectin‐3, the Root Cause of Oligomerization of Amyloid Proteins
3分钟前
待确认
Assessment of Baseline Plasma p‐tau217 in TANGO, a Randomized, Placebo‐controlled Phase 2 Study of Gosuranemab in Patients with Early Alzheimer’s Disease
17小时前
已关闭
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
17小时前
已完结
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
19小时前
已完结
O4‐04‐03: Additional results from a phase ii study to assess the clinical and immunological activity, safety, and tolerability of affitope® ad02 in patients with early Alzheimer's disease (AD)
1天前
已完结
Should I stay or should I go? Transsulfuration influences invasion and growth in glioblastoma
6天前
已完结
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis
25天前
已完结
Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis
25天前
已完结
Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer’s disease co-pathology and behavior impairments
25天前
已完结
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016–2019)
25天前
已完结
皖公网安备34019202002308
